Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes

GR Bebernitz, V Beaulieu, BA Dale…

Index: Journal of Medicinal Chemistry, , vol. 52, # 19 p. 6142 - 6152

Full Text: HTML

Citation Number: 69

Abstract

... Journal of Medicinal Chemistry. ... 10−15 years. Glucokinase (GK) activators are currently under investigation by a number of pharmaceutical companies with only a few reaching early clinical evaluation. A GK activator ...

Related Articles:

Studies in the heterocyclic series. XVI. Open azaphenothiazines as new central nervous system depressants.

[Chemical and Pharmaceutical Bulletin, , vol. 30, # 1 p. 302 - 318]

Studies in the heterocyclic series. XVI. Open azaphenothiazines as new central nervous system depressants.

[Chemical and Pharmaceutical Bulletin, , vol. 30, # 1 p. 302 - 318]

A single??step preparation of thiazolo [5, 4??b] pyridine??and thiazolo [5, 4??c] pyridine derivatives from chloronitropyridines and thioamides, or thioureas

[Journal of Heterocyclic Chemistry, , vol. 46, # 6 p. 1125 - 1131]

Synthesis of analogues of the 2, 3, 6,??triazaphenothiazine ring system

[Journal of Heterocyclic Chemistry, , vol. 20, # 1 p. 199 - 203]

More Articles...